Sign in
OMIC Stock Price, Chart, Stats & News
Singular Genomics Systems, Inc.
Save
50.77M
Market cap
–
Current P/E
–
Forward P/E
OMIC chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -19.17% |
Operating margin | -3531.47% |
Pretax margin | -3257.30% |
Net margin | -3257.30% |
Effective tax rate | – |
ROA | -35.72% |
ROE | -43.17% |
D/E | 0.42x |
Interest coverage ratio | -93.37x |
OMIC valuation
P/E | – |
P/S | 17.44x |
P/B | 0.27x |
P/CF | -0.66x |
P/FCF | -0.68x |
P/OCF | -0.66x |
PEG | -0.08x |
EV multiple | 0.10x |
About
Singular Genomics Systems, Inc. is a life science technology firm focused on creating advanced next-generation sequencing and multiomics solutions. The company aims to provide researchers and clinicians with innovative tools to accelerate scientific discovery and medical advancements. Among its core products is the G4 Instrument, a compact next-generation sequencer designed to deliver genetic sequencing results, supported by a selection of complementary consumable kits.
Similar securities
Based on sector and market capitalization
Report issue